How Predictive In Vitro Assays May Improve Nanomedicine
Researchers published a study on the design and application of nanoparticles as efficient delivery vehicles for biopharmaceutics.
Read MorePosted by Andy Lundin | Feb 1, 2022 | Molecular Diagnostics |
Researchers published a study on the design and application of nanoparticles as efficient delivery vehicles for biopharmaceutics.
Read MorePosted by Andy Lundin | Jan 28, 2022 | Covid 19 |
The severity of COVID-19 pneumonia can be difficult to assess in people from different ethnic groups, due to inaccurate readings from pulse oximeters.
Read MorePosted by Andy Lundin | Jan 27, 2022 | Diagnostic Technologies, Respiratory Disease |
LightDeck Diagnostics received a $2 million contract for the development of a rapid, quantitative, multiplexed test for inflammatory markers.
Read MorePosted by Andy Lundin | Jan 27, 2022 | Diabetes & Metabolic Diseases, Diagnostic Technologies |
The ELF Test is a blood test that assesses prognosis in patients with advanced fibrosis due to non-alcoholic steatohepatitis (NASH).
Read MorePosted by Andy Lundin | Jan 24, 2022 | Anatomic Pathology, Rapid Assays |
The FDA has granted Pathogenomix with a Breakthrough Device Designation for its Patho-Seq assay due to its methodologies of pathogenic bacteria diagnosis.
Read More